Acoustic Mass Spectrometry for Screening Biological Targets
Jonathan Wingfield, Principal Scientist at AstraZeneca, describes how acoustic mass spectrometry technology being used to screen biological targets.
We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Jonathan Wingfield, Principal Scientist at AstraZeneca, describes how acoustic mass spectrometry technology being used to screen biological targets.